285 related articles for article (PubMed ID: 34080683)
1. Comparison of the EUROIMMUN Dermatology Profile ELISA to the novel BIOCHIP Mosaic 7 for the diagnosis of immunobullous skin disease.
Simpson K; Scardamaglia L; Kok Y; Vu M; Kidd D; Yap T; Tran Y; Kern JS
Australas J Dermatol; 2021 Aug; 62(3):314-322. PubMed ID: 34080683
[TBL] [Abstract][Full Text] [Related]
2. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
Atzori L; Deidda S; Aste N
G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
[TBL] [Abstract][Full Text] [Related]
3. A new indirect immunofluorescence BIOCHIP method for the serological diagnosis of bullous pemphigoid: A review of literature.
Yang A; Xuan R; Murrell DF
Australas J Dermatol; 2019 Aug; 60(3):e173-e177. PubMed ID: 30968398
[TBL] [Abstract][Full Text] [Related]
4. Validation of the BIOCHIP test for the diagnosis of bullous pemphigoid, pemphigus vulgaris and pemphigus foliaceus.
Yang A; Xuan R; Melbourne W; Tran K; Murrell DF
J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):153-160. PubMed ID: 31260565
[TBL] [Abstract][Full Text] [Related]
5. Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy.
van Beek N; Rentzsch K; Probst C; Komorowski L; Kasperkiewicz M; Fechner K; Bloecker IM; Zillikens D; Stöcker W; Schmidt E
Orphanet J Rare Dis; 2012 Aug; 7():49. PubMed ID: 22876746
[TBL] [Abstract][Full Text] [Related]
6. Inter-rater reliability of the BIOCHIP indirect immunofluorescence dermatology mosaic in bullous pemphigoid and pemphigus patients.
Yang A; Xuan RR; Melbourne W; Hashimoto T; Uzun S; Daneshpazhooh M; Yamagami J; Di Zenzo G; Mascaro JM; Mahmoudi H; Patsatsi A; Drenovska K; Vassileva S; Murrell DF
J Eur Acad Dermatol Venereol; 2019 Dec; 33(12):2327-2333. PubMed ID: 31325388
[TBL] [Abstract][Full Text] [Related]
7. The Value of the BIOCHIP Mosaic-based Indirect Immunofluorescence Technique in the Diagnosis of Pemphigus and Bullous Pemphigoid in Turkish Patients.
Özkesici B; Mutlu D; Dönmez L; Uzun S
Acta Dermatovenerol Croat; 2017 Oct; 25(3):202-209. PubMed ID: 29252172
[TBL] [Abstract][Full Text] [Related]
8. BIOCHIP mosaic for the diagnosis of autoimmune bullous diseases in Chinese patients.
Wang M; Li F; Wang X; Wang R; Chen T; Zhao J; Chen X; Zhu X
Eur J Dermatol; 2020 Aug; 30(4):338-344. PubMed ID: 32969793
[TBL] [Abstract][Full Text] [Related]
9. Autoantibody detection in bullous pemphigoid: clinical evaluation of the EUROPLUS™ Dermatology Mosaic.
Damoiseaux J; van Rijsingen M; Warnemünde N; Dähnrich C; Fechner K; Tervaert JW
J Immunol Methods; 2012 Aug; 382(1-2):76-80. PubMed ID: 22580378
[TBL] [Abstract][Full Text] [Related]
10. Anti-skin specific autoantibodies detected by a new immunofluorescence multiplex biochip method in patients with autoimmune bullous diseases.
Tampoia M; Zucano A; Villalta D; Antico A; Bizzaro N
Dermatology; 2012; 225(1):37-44. PubMed ID: 22907099
[TBL] [Abstract][Full Text] [Related]
11. Role of BIOCHIP Indirect Immunofluorescence Test in Cutaneous Vesiculobullous Diseases.
Tirumalae R; Kalegowda IY
Am J Dermatopathol; 2020 May; 42(5):322-328. PubMed ID: 31211701
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Role of BIOCHIP Mosaic Based Indirect Immunofluorescence and ELISA BP 180 and BP 230 Autoantibodies in the Diagnosis of Bullous Pemphigoid Patients.
Nithya V; Rai R; Boppe A; Chaithra V
Indian Dermatol Online J; 2022; 13(6):754-756. PubMed ID: 36386758
[TBL] [Abstract][Full Text] [Related]
13. Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology.
van Beek N; Krüger S; Fuhrmann T; Lemcke S; Goletz S; Probst C; Komorowski L; Di Zenzo G; Dmochowski M; Drenovska K; Horn M; Jedlickova H; Kowalewski C; Medenica L; Murrell D; Patsatsi A; Geller S; Uzun S; Vassileva S; Zhu X; Fechner K; Zillikens D; Stöcker W; Schmidt E; Rentzsch K
J Am Acad Dermatol; 2020 Nov; 83(5):1315-1322. PubMed ID: 32004645
[TBL] [Abstract][Full Text] [Related]
14. The use of BIOCHIP mosaics in diagnostics of bullous pemphigoid: Evaluation and comparison to conventional multistep procedures.
Adaszewska A; Kalińska-Bienias A; Jagielski P; Woźniak K; Kowalewski C
J Cutan Pathol; 2020 Feb; 47(2):121-127. PubMed ID: 31603994
[TBL] [Abstract][Full Text] [Related]
15. Dual diagnosis of Pemphigus and pemphigoid. Retrospective review of thirty cases in the literature.
Sami N; Ahmed AR
Dermatology; 2001; 202(4):293-301. PubMed ID: 11455140
[TBL] [Abstract][Full Text] [Related]
16. Comparative Analysis of BIOCHIP Mosaic-based Indirect Immunofluorescence with Direct Immunofluorescence in Diagnosis of Autoimmune Bullous Diseases: A Cross-Sectional Study.
Arunprasath P; Rai R; Venkataswamy C
Indian Dermatol Online J; 2021; 12(1):105-109. PubMed ID: 33768030
[TBL] [Abstract][Full Text] [Related]
17. Comparative Analysis of BIOCHIP Mosaic-Based Indirect Immunofluorescence with Direct Immunofluorescence in Diagnosis of Autoimmune Bullous Diseases: A Cross-Sectional Study.
Arunprasath P; Rai R; Venkataswamy C
Indian Dermatol Online J; 2020; 11(6):915-919. PubMed ID: 33344339
[TBL] [Abstract][Full Text] [Related]
18. The use of biochip immunofluorescence microscopy for the diagnosis of Pemphigus vulgaris.
Russo I; Saponeri A; Peserico A; Alaibac M
Acta Histochem; 2014 Jun; 116(5):713-6. PubMed ID: 24485334
[TBL] [Abstract][Full Text] [Related]
19. [Modern diagnostics of autoimmune bullous diseases].
van Beek N; Schumacher N; Rose C; Schmidt E; Zillikens D
Pathologe; 2020 Jul; 41(4):317-325. PubMed ID: 32542511
[TBL] [Abstract][Full Text] [Related]
20. Biochip detection of BP180 autoantibodies in blister fluid for the serodiagnosis of bullous pemphigoid: A pilot study.
Sernicola A; Russo I; Saponeri A; Alaibac M
Medicine (Baltimore); 2019 Feb; 98(7):e14514. PubMed ID: 30762788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
